CCL2 and neoplasm: These factors, in turn, enhance migration of tumor cells.36 In addition, when targeting the CCL2/CCR2 chemokine axis, TAMs infiltration at the metastatic site is reduced and metastatic CRC (mCRC) is sensitized to tumor T cells.37